FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (2484 ms)

Resources - All Kinds, Realm EU

873 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

By Authority

Start Prev Rows 400 - 600 Next
PackageVersionIdentityName/TitleStatusDateAuth
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/metastasis-disorder-athena-vs Metastatis: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-athena-i4rc Subsites: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/occurrence-other-cancer-i4rc Occurrence of other canceractive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalM-i4rc Pathological Mactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalN-i4rc Pathological Nactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalT-i4rc Pathological Tactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/race-i4rc Raceactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/setting-radiotherapy-i4rc Setting Radiotherapyactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/simpleResult-eu-i4rc Simple measuresactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/site-of-metastasis-i4rc Site of metastasisactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/site-qualifier-i4rc Body site qualifieractive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/siteRare-i4rc Site rare (IDEA4RC)active2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/status-last-followup-i4rc Status at the Last Follow Upactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/surgery-complication-eu-i4rc Surgery Complicationactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/surgery-intention-eu-i4rc Surgery Intentionactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/surgery-outcome-eu-i4rc Surgery Outcomeactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/surgical-complications-eu-i4rc Surgical Complicationsactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/tobacco-product-eu-i4rc Tobacco Productactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/treatment-response-eu-i4rc Treatment Responseactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/treatment-setting-eu-i4rc Treatment Settingactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/treatment-technique-i4rc Treatment Techniqueactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/type-of-biopsy-eu-i4rc Type of Biopsyactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/type-of-treatment-eu-i4rc Type of Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-calcest-eu-i4rc Calculated|Estimateddraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-07hl7
hl7.eu.fhir.idea4rcR4ValueSet/yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-07hl7
hl7.fhir.eu.baseR4CodeSystem/v3-ActCode-EU HL7 V3 ActCode - EU extensionsdraft2024-09hl7
hl7.fhir.eu.baseR4ImplementationGuide/hl7.fhir.eu.base HL7 Europe Base Profilesdraft2024-09hl7
hl7.fhir.eu.baseR4StructureDefinition/Coverage-eu-ehic Coverage: EHIC draft2024-09hl7
hl7.fhir.eu.baseR4http://hl7.eu/fhir/ig/base/StructureDefinition/EHIC European Health Insurance Carddraft2024-09hl7
hl7.fhir.eu.baseR4StructureDefinition/Patient-eu-ehic Patient (EHIC)draft2024-09hl7
hl7.fhir.eu.baseR4ValueSet/iso-ehicCountryCode ISO 3166 - EHIC Country Codesdraft2024-09hl7
hl7.fhir.eu.baseR4ValueSet/oid-ehicPersonalId EHIC Personal ID (system IDs - oid) draft2024-09hl7
hl7.fhir.eu.baseR4ValueSet/uri-ehicPersonalId EHIC Personal ID (system IDs - uri) draft2024-09hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000093533 ATC Human EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072052 Marketing Status EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000008 Combination Package EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000006 Combined Pharmaceutical Dose Form EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000007 Combined Term EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000002 Country EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000004 Domain EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072057 Language EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072051 Legal Status for the Supply EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000003199 Material EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073346 Packaging EMA SPORdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000004 Pharmaceutical Dose Form EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000005003 Record Status EMA SPORdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072049 Regulatory Entitlement Status EMA SPORdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073345 Routes and Methods of Administration EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v2/SubstanceDefinition Substances EMA SPOR SMSdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000110633 Unit of Measurement EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000014 Unit of Presentation EMAdraft2024-10hl7
hl7.eu.fhir.unicomR5ConceptMap/edqm-ema-pharmaceuticalDoseForm-cm EDQM-SPOR Pharmaceutical dose formsdraft2024-10hl7
hl7.eu.fhir.unicomR5ConceptMap/sms-snomed-substance-cm SPOR-SNOMED CT substancesdraft2024-10hl7
hl7.eu.fhir.unicomR5ImplementationGuide/hl7.eu.fhir.unicom UnicomIGdraft2024-10hl7
hl7.eu.fhir.unicomR5OperationDefinition/Equivalent Equivalent Look Upactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-packaging-ppd manufactured-item-packaging-ppdactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-ppd manufactured-item-ppdactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/country countryactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/name-language-correct name-language-correctactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/reference-strength-substance reference-strength-substanceactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-quantity strength-presentation-quantityactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-denominator strength-presentation-ratio-numeratoractive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-numerator strength-presentation-ratio-numeratoractive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio strength-presentation-ratioactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-quantity-and-substance strength-quantity-and-substanceactive2024-10hl7
hl7.eu.fhir.unicomR5SearchParameter/strength-ratio-and-substance strength-ratio-and-substanceactive2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/AD ADdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/ANY ANYdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/BL BLdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/CD CDdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/Class Classdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/CrossBorderProduct DRAFT: Medicinal Product in crossborder eP/eDdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/DT DTdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/EN ENdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/FullMedicinalProduct Medicinal Product Logical Modeldraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/II IIdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/INT INTdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/ManufacturedMaterial DRAFT: MyHealth@EU medicinal productdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsManufacturedItem Medication as manufactured itemdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsMedicinalProduct Medicationdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/MedicationModel Medication for clinical workflowsdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLAdministrableProductDefinition PPL Administrable Product profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLIngredient PPL Ingredient profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLManufacturedItemDefinition PPL Manufactured Item profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLMedicinalProductDefinition PPL Medicinal Product profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLOrganization PPL Organizationdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLPackagedProductDefinition PPL Packaged Product profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PPLRegulatedAuthorization PPL Marketing Authorisation profiledraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/PQ PQdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/REAL REALdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/RTO RTOdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/ST STdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/SctClinicalDrug SNOMED CT Clinical Drugdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TS TSdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionAdministrableProductDefinition Processing Profile - Administrable Productdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionIngredient Processing Profile - Ingredientdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionManufacturedItemDefinition Processing Profile - Manufactured Itemdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionMedicinalProductDefinition Processing Profile - Medicinal Productdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionOrganization Processing Profile - Organizationdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionPackagedProductDefinition Processing Profile - Packaged Productdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/TransitionRegulatedAuthorization Processing Profile - Marketing Authorisationdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/Untyped Untypeddraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/administrable-doseform AdministrableDoseFormdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-classification MedicinalProductClassificationdraft2024-10hl7
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-name MedicinalProductNamedraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/administration-device EDQM Administration Deviceactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/administration-method EDQM Administration Methodactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/all-units-vs EMA SPOR All Units Combineddraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/atc-spor-vs EMA SPOR ATCdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/authorised-doseform-vs EMA SPOR Authorised Dose Formdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/basic-dose-form EDQM Basic Dose Formactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/closure EDQM Closureactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/combination-pack EDQM Combination Packactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/combined-pharmaceutical-dose-form EDQM Combined Pharmaceutical Dose Formactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/combined-term EDQM Combined Termactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/container EDQM Containeractive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/country-ema-vs EMA SPOR Countrydraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/country-iso-vs Country (ISO 3166-1-2)draft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/domain-vs EMA SPOR Domaindraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/ehdsi-ucum-unit MyHealth@EU Unit of Measurement (UCUM)active2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/intended-site EDQM Intended Siteactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/language-bcp-vs Language (FHIR)draft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/language-ema-vs EMA SPOR Languagedraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/legal-status-for-the-supply-vs EMA SPOR Legal Status for the Supplydraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/marketing-status-spor-vs EMA SPOR Marketing Statusdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/material-vs EMA SPOR Materialdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/packaging-category EDQM Packaging Categoryactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/packaging-spor-vs EMA SPOR Packagingdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/patient-friendly-term EDQM Patient-friendly Termactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/pharmaceutical-dose-form EDQM Pharmaceutical Dose Formactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/pharmaceutical-doseform-vs EMA SPOR Pharmaceutical Dose Formdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/record-status-spor-vs EMA SPOR Record Statusdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/regulatory-status-spor-vs EMA SPOR Regulatory Entitlement Statusdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/route-of-administration EDQM Route of Administrationactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/routes-and-methods-of-administration-vs EMA SPOR Routes and Methods of Administrationdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/shelflifetype-spor-vs EMA SPOR Shelf Life Typedraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/substances-vs EMA SPOR SMS Substancesdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/unit-of-measurement-vs EMA SPOR Unit of Measurementdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/unit-of-presentation-vs EMA SPOR Unit of Presentationdraft2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/unit-of-presentation EDQM Unit of Presentationactive2024-10hl7
hl7.eu.fhir.unicomR5ValueSet/whoatc-unicom WHO ATCactive2024-10hl7
hl7.fhir.eu.laboratoryR4http://example.org/lab-codes Laboratory Code: exampledraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/author2FHIR-eu-lab eHN Author to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/labRpt2FHIR-eu-lab eHN Lab Report to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/legalAuth2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/order2FHIR-eu-lab eHN Order to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/payer2FHIR-eu-lab eHN Payer to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/recipient2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/result2FHIR-eu-lab eHN Result to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/specimen2FHIR-eu-lab eHN Specimen to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/subject2FHIR-eu-lab eHN Subject to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ConceptMap/validator2FHIR-eu-lab eHN Validator to this guide Mapdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ImplementationGuide/hl7.fhir.eu.laboratory HL7 Europe Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Address-eu Address (EU)draft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Author A.1.5 - Authordraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/BodyStructure-eu-lab Body structure: Laboratorydraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Bundle-eu-lab Bundle: Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Composition-eu-lab Composition: Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/DiagnosticReport-eu-lab DiagnosticReport: Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/HumanName-eu HumanName (Eu)draft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/HumanName-obl-eu-lab Human Name: Obligationsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/LabReport A - Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/LegalAuthenticator A.1.6 - Legal authenticatordraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Observation-obl-eu-lab Observation: Obligationsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Observation-resultslab-eu-lab Observation Results: laboratorydraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Order A2, A3 - Orderdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Patient-animal-eu-lab Patient: Animaldraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Patient-eu-lab Patient: Persondraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Patient-obl-eu-lab Patient: Obligationsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Payer A.1.3 - Health insurance and payment informationdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Practitioner-eu-lab Practitioner: Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/PractitionerRole-eu-lab PractitionerRole: Laboratory Reportdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Quantity-eu-lab Quantity (Eu Lab)draft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Ratio-eu-lab Ratio (Eu Lab)draft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Recipient A.1.4 - Information recipientdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Result A.5 - Results data elementsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/ServiceRequest-eu-lab ServiceRequest: Laboratory Orderdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/ServiceRequest-obl-eu-lab ServiceRequest: Obligationsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Specimen-eu-lab Specimen: Laboratorydraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Specimen-obl-eu-lab Specimen: Obligationsdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/SpecimenLab A.4 - Specimen informationdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Substance-additive-eu-lab Substance: Specimen Additive Substancedraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/Validator A.1.7 - Result validatordraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/composition-diagnosticReportReference Document DiagnosticReport Referencedraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-certifiedRefMaterialCodeable Certified Reference Material: CodeableConceptdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-certifiedRefMaterialIdentifer Certified Reference Material: Identifierdraft2024-10hl7
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-deviceLabTestKit Device Laboratory Test Kitdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-certifiedRefMaterial-eu-lab Laboratory Certified Reference Materialdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-laterality-eu-lab Body Structure Lateralitydraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-eu-lab Laboratory Codedraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-loinc-eu-lab Laboratory Code: LOINCdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-npu-eu-lab Laboratory Code: NPUdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-orderCodes-eu-lab Laboratory Orderdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-reportType-eu-lab Laboratory Report Typesdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-siteQualifier-eu-lab Body Structure Qualifierdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-specialty-eu-lab Laboratory Specialtydraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-speciesType-eu-vs Types of speciesdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenAdditive-eu-lab Specimen Additivedraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenContainer-eu-lab Specimen Containerdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenType-eu-lab Specimen Typesdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-studyType-eu-lab Laboratory Study Typesdraft2024-10hl7
hl7.fhir.eu.laboratoryR4ValueSet/lab-technique-eu-lab Laboratory Techniquesdraft2024-10hl7
hl7.fhir.eu.hdrR4CodeSystem/assessment-category-eu-hdr Xpandh Assessment Categoryactive2024-10hl7
hl7.fhir.eu.hdrR4CodeSystem/poa-indicator-eu-hdr Present on Admission (POA) Indicatordraft2024-10hl7
hl7.fhir.eu.hdrR4CodeSystem/whodas-20-cs WHO Disability Assessment Schedule 2.0active2024-10hl7
hl7.fhir.eu.hdrR4ConceptMap/encounter2FHIR-eu-hdr eHN Encounter Model to this guide Mapdraft2024-10hl7
hl7.fhir.eu.hdrR4ConceptMap/hdrHeader2FHIR-eu-hdr eHN Header Model to this guide Mapdraft2024-10hl7
hl7.fhir.eu.hdrR4ImplementationGuide/hl7.fhir.eu.hdr HL7 Europe Hospital Discharge Reportdraft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/AdmissionEvaluation A.2.4 - Admission evaluation (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/AdvanceDirectives A.2.1 - Advance Directives (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/Alerts A.2.2 - Alerts (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/DischargeDetails A.2.8 - Discharge details (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/Header A.1 - Hospital Discharge Report header data elementdraft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/HospitalDischargeReport A - Hospital Discharge Report (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/HospitalStay A.2.7 - Hospital stay (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/InPatientEncounter A.2.3 - Encounter (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/PatientHistory A.2.6 - Patient history (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/Recommendations A.2.9 - Care plan and other recommendations after discharge (eHN)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/bundle-eu-hdr Bundle (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/composition-eu-hdr Composition (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/encounter-eu-hdr Encounter (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/location-eu-hdr Location (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/organization-eu-hdr Organization (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/patient-eu-hdr Patient (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/practitioner-eu-hdr Practitioner (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4StructureDefinition/practitionerRole-eu-hdr PractitionerRole: (HDR)draft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-M-category-vs TNM M Categoryactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-M-clinical-category-vs Clinical Mactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-M-pathologycal-category-vs Pathological Mactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-N-category-vs TNM N Categoryactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-N-clinical-category-vs Clinical Nactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-N-pathological-category-vs Pathological Nactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-T-category-vs Primary tumor Tactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-T-clinical-category-vs Clinical Tactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/TNM-T-pathological-category-vs Clinical Tactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/admission-urgency-eu-hdr Admission Urgency Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/admission-voluntary-status-vs Encounter Voluntary Status Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-eu-hdr Allergy Intolerance (with exceptions)draft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-substances-eu-hdr Allergy Intolerancedraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/anthropometric-observation-vs Anthropometric Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/assessment-observation-category-vs Xpandh Assessment Observation Categoryactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/bmi-observation-unit-vs BMI Observation Unit Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/bmi-observation-vs BMI Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/body-height-observation-vs Body Height Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/body-weight-observation-vs Body Weight Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/body-weight-units-vs Body Weight Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/cancer-stage-grading-vs Cancer Stage Grading: Snomed CTdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/cancer-stageGroup-vs Cancer Stage Group: SNOMED CTdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/circumference-observation-vs Circumference Observation Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/condition-eu-hdr Condition Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/condition-mandatory-eu-hdr Mandatory Condition Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/encounter-status-eu-hdr In-patient Encounter Type Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/functional-assessment-scales-vs Xpandh Functional Assessment Scalesactive2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/hdr-encounter-type-eu-hdr In-patient Encounter Type Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/hdr-encounterClass-eu-hdr Encounter Class Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/hdr-treated-eu-hdr Treatment Class Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/medical-devices-eu-hdr Medical Devices (SNOMED CT) - Xpandhdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/medical-devices-snomed-absent-unknown-eu-hdr Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/skinfold-thickness-units-vs Skinfold Thickness Units Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/skinfold-thickness-vs Skinfold Thickness Value Setdraft2024-10hl7
hl7.fhir.eu.hdrR4ValueSet/vital-signs-observation-vs Vital Signs Observation Value Setdraft2024-10hl7
hl7.fhir.eu.mpdR4ConceptMap/eD2FHIR-eu-mpd eHN Dispense to this guide Mapdraft2024-10hl7
hl7.fhir.eu.mpdR4ConceptMap/eP2FHIR-eu-mpd eHN Subject to this guide Mapdraft2024-10hl7
hl7.fhir.eu.mpdR4ConceptMap/medProd2FHIR-eu-mpd eHN Medicinal Product to this guide Mapdraft2024-10hl7
hl7.fhir.eu.mpdR4ImplementationGuide/hl7.fhir.eu.mpd HL7 Europe Medication Prescription and Dispensedraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/Dispensation B.1 Dispensation information (provided by the dispensing pharmacy)draft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/Medication-eu-mpd Medication: MPDdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/MedicationDispense-eu-mpd MedicationDispense: MPDdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/MedicationRequest-eu-mpd MedicationRequest: MPDdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/MedicinalProduct A1.4 Identification of the prescribed productdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/Patient-eu-mpd Patient: MPDdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/Prescription A - Prescriptiondraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/Subject A.1.1 Patient administrative datadraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-characteristic Medication - Characteristicdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-classification Medication - Classificationdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-device Medication - Devicedraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-productname Medication - Product Namedraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-sizeofitem Medication - Size of Itemdraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-strengthsubstance Medication - Strength substancedraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-strengthtype Medication - Strength typedraft2024-10hl7
hl7.fhir.eu.mpdR4StructureDefinition/ihe-ext-medication-unitofpresentation Medication - Unit of presentationdraft2024-10hl7
hl7.eu.fhir.ghepiR5ImplementationGuide/hl7.eu.fhir.ghepi Gravitate Health FHIR Implementation Guideactive2024-10hl7
hl7.eu.fhir.pcspR4CodeSystem/cs-generic-eu-pcsp PCSP Code Systemdraft2024-09hl7
hl7.eu.fhir.pcspR4CodeSystem/cs-radiotherapy-pcsp Radiotherapy sitesactive2024-09hl7
hl7.eu.fhir.pcspR4CodeSystem/cs-recommendation-eu-pcsp PCSP Recommendationsdraft2024-09hl7
hl7.eu.fhir.pcspR4CodeSystem/cs-riskcondition-eu-pcsp PCSP Conditions at riskdraft2024-09hl7
hl7.eu.fhir.pcspR4CodeSystem/cs-riskfactor-eu-pcsp Risk Factorsdraft2024-09hl7
hl7.eu.fhir.pcspR4ImplementationGuide/hl7.eu.fhir.pcsp PanCareSurPass Project HL7 FHIR Implementation Guidedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/BiologicallyDerivedProduct-sct-eu-pcsp BiologicallyDerivedProduct: Stem Celldraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Bundle-eu-pcsp Bundle: Survivor Passportdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/CarePlan-eu-pcsp CarePlan: PCSP-generated plandraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Chemotherapy Chemotherapydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Composition-surpass-eu-pcsp Composition: Survivor Passportdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Condition-gvhd-eu-pcsp Condition: GvHDdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Condition-otherinfos-eu-pcsp Condition: Othersdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Condition-primaryCancer-eu-pcsp Condition: Primary Cancerdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Condition-secondaryCancer-eu-pcsp Condition: Metastatic Cancerdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Condition-toxicity-eu-pcsp Condition: Severe Toxicitydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Diagnosis Diagnosisdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/DocMetadataFSE Metadata FSE Italydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/DocumentReference-eu-pcsp DocumentReference: PCSPdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Encounter-eu-pcsp Encounter: Treatment Centerdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/FrontLineTreatment Front Line Treatmentdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Location-eu-pcsp Location: PCSPdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/MajorSurgery Major Surgerydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/MedicationAdministration-eu-pcsp MedicationAdministration: Chemotherapydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/MedicationStatement-eu-pcsp MedicationStatement: Chemotherapydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-bld-abo-rh-eu-pcsp Observation: Blood type/RHdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-cumulativeDoseChemo-eu-pcsp Observation: Chemotherapy Cumulative Dosedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-diagnosis-eu-pcsp Observation: Diagnosis detailsdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-predisposition-eu-pcsp Observation: Hereditary Predispositiondraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-riskfactor-eu-pcsp Observation: Risk Factordraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Observation-totalDoseRad-eu-pcsp Observation: Radiotherapy Total Dose PCSPdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Organization-center-eu-pcsp Organization: Primary Treatment Center / Center of diagnosisdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/OtherInfos Other info and relevant eventsdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Patient-eu-pcsp Patient: PCSPdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/PlanDefinition-flt-eu-pcsp PlanDefinition: Front Line Treatmentdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/PlanOfCare Care Plandraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-cryopreservation-otherinfos-eu-pcsp Procedure: Cryopreservationdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-cvc-otherinfos-eu-pcsp Procedure: Catheterdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-flt-eu-pcsp Procedure: Front Line Treatmentdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphy-eu-pcsp Procedure: Radiotherapydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphyBoost-eu-pcsp Procedure: Radiotherapy Boostdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphyShield-eu-pcsp Procedure: Radiotherapy Shieldingdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-sct-eu-pcsp Procedure: Stem Cell Transplantationdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-sct-prophylaxis-eu-pcsp Procedure: SCT Prophylaxisdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-surgery-eu-pcsp Procedure: Surgerydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-transfusion-otherinfos-eu-pcsp Procedure: Transfusion other infosdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-treatment-otherinfos-eu-pcsp Procedure: Other Treatmentsdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Radiotherapy Radiotherapydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/RelapseAfterFLT Progression-Relapse after FLTdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/RelapseDuringFLT Progression-Relapse during FLTdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/StemCellTransplantation Stem Cell Transplantationdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/Subject Subject of caredraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/SurPass SurPass V2.0draft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/TreatmentSummary Treatment Summarydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/annotation-type Annotation Typedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/condition-previousStatus Previous Statusdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/condition-relapseType Relapse Typedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/event-location Act Locationdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-cancer-stage-group Observation: Cancer Stage Groupdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-condition-related Condition related to resourcedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/procedure-fltArm Randomization arm for trialdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/procedure-notAffectedOrgan Not affected Organdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/procedure-performedTiming Performed Timingdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/procedure-usedReference Procedure Used Referencedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/resource-relatedInfo Resource related informationdraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/sct-donor-type Stem Cell Donor Typedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/sct-source-type Stem Cell Source Typedraft2024-09hl7
hl7.eu.fhir.pcspR4StructureDefinition/surgery-sacrifiedOrgan Sacrified organdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/ChemoUnitsVs Chemotherapy cumulative dose unitsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/activeResolved-condition-vs Active or resolved Conditiondraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/annotation-type-vs Annotation typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/cond-test-vs Conditions: follow updraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/drugsAtc-eu-pcsp Antineoplastic and immunostimulating agentsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/grade-test-vs Grade: follow updraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/laterality-qualifier-lrub-vs Laterality Qualifier Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-body-location-qualifier-vs Body Location Qualifier Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-cancer-stage-group-vs Stage Group Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-cancer-staging-system-vs Cancer Staging System Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-stage-group-vs Observation Codes for Stage Group Categorydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/morphologicAbnormality-eu-vs Morphologically abnormal structuredraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/otherInfos-condition-vs Other Infors Conditiondraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/relapse-type-vs Relapse type (Local/Distant/Combined)draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/toxicityseverity-vs Toxicity Severitydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-acute-grade-eu-pcsp Acute Gvhd Gradedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-chronic-grade-eu-pcsp Chronic Gvhd conditiondraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-type-eu-pcsp Gvhd conditiondraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-ProsthesisType-eu-pcsp Prosthesis Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-ProstheticProcedureType-eu-pcsp Prosthetic Surgical Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-action-eu-pcsp Surgical Actionsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-affectedOrgan-eu-pcsp Affected Organs (surgery)draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-amputationProcedureType-eu-pcsp Amputation Surgical Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-brachytherapyType-eu-pcsp Brachytherapy Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-calcest-eu-pcsp Calculated|Estimateddraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-colostomyProcedureType-eu-pcsp Colostomy Surgical Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-docref-doctype-eu-pcsp Document Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-flt-plan-type-eu-pcsp FLT Plan Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-fromToPosteriorAnterior-eu-pcsp Body Location Qualifier Value Setdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-gastrostomyProcedureType-eu-pcsp Gastrostomy Surgical Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-hereditary-eu-pcsp Hereditary Predispositions or Diseasedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-iccc3-eu-pcsp ICCC-3draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-icd10-predisposition-eu-pcsp Hereditary Predispositions (ICD10)draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-icdo3-morphology-eu-pcsp ICD-O-3 Morphologydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-icdo3-topography-eu-pcsp ICD-O-3 Topographydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-isotopes-eu-pcsp Radiotherapy Isotopesdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-naunk-eu-pcsp Not Applicable|Unknowndraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-npunk-eu-pcsp Not Performed|Unknowndraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-orpha-predisposition-eu-pcsp Hereditary Predispositions (Orphacode)draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-othUnkTxt-eu-pcsp Other/Unknown/Textdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-radiotherapy-pcsp Radiotherapy sitesdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-radiotherapyDeviceType-eu-pcsp Radiotherapy Device Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-radiotherapyDoseType-eu-pcsp Radiotherapy Dose Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-radiotherapyDoseUnit-eu-pcsp Radiotherapy dose unitsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-radiotherapyType-eu-pcsp Radiotherapy Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-recommendation-eu-pcsp Recommendationsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-riskcondition-eu-pcsp Conditions at riskdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-riskfactor-eu-pcsp Risk Factorsdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-roa-eu-pcsp Route of administrationdraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sacrifiedOrgan-eu-pcsp Sacrified Organs (surgery)draft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-donorType-eu-pcsp Stem Cell Donor typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-prophylaxis-cathegory-eu-pcsp SCT Prophylaxis Cathegorydraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-prophylaxis-type-eu-pcsp SCT Prophylaxis Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-sourceType-eu-pcsp Stem Cell Source typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-timing-eu-pcsp Before/after proceduredraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-sct-type-eu-pcsp Stem Cell Transplantation typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-shuntProcedureType-eu-pcsp Shunt Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-surgicalProcedureType-eu-pcsp Surgical Procedure Typedraft2024-09hl7
hl7.eu.fhir.pcspR4ValueSet/vs-unknownOther-eu-pcsp Unknown|Otherdraft2024-09hl7
hl7.eu.fhir.gh-ipsR4ImplementationGuide/hl7.eu.fhir.gh-ips Gravitate Health FHIR Implementation Guide (FHIR R4)active2024-10hl7
hl7.eu.fhir.xpandh.labR4CodeSystem/lab-localCs-xpandh Laboratory local codes Code Systemactive2024-09hl7
hl7.eu.fhir.xpandh.labR4ConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4ImplementationGuide/hl7.eu.fhir.xpandh.lab XpanDH Laboratory Reportdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/Bundle-lab-xpandh Bundle: Laboratory Reportdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/Composition-lab-xpandh Composition: Laboratory Reportdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/DiagnosticReport-lab-xpandh DiagnosticReport: Laboratory Reportdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/Observation-results-lab-xpandh Observation Results: laboratorydraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/Patient-eu-xpandh Patientdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/Practitioner-eu-xpandh Practitionerdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/PractitionerRole-eu-xpandh PractitionerRoledraft2024-09hl7
hl7.eu.fhir.xpandh.labR4StructureDefinition/ServiceRequest-lab-xpandh ServiceRequest: Laboratory Orderdraft2024-09hl7
hl7.eu.fhir.xpandh.labR4ValueSet/lab-localVs-xpandh Local Laboratory Codes VSdraft2024-09hl7
hl7.fhir.eu.extensionsR4ImplementationGuide/hl7.fhir.eu.extensions HL7 Europe Extensionsactive2024-02hl7
hl7.fhir.eu.extensionsR4http://hl7.eu/fhir/StructureDefinition/composition-basedOn-order-or-requisition Document Based On Orderactive2024-02hl7
hl7.fhir.eu.extensionsR4http://hl7.eu/fhir/StructureDefinition/information-recipient Information recipientactive2024-02hl7

XIG built as of 17 Oct 2024. Found 40652 resources in 683 packages.